SCHEMBL17469513

SCHEMBL17469513

CNCCN(C)Cc1n[nH]c2ccc(Oc3cccc(C#N)c3)cc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 1/20 0.40
▸ WDR77 Q9BQA1 1/20 0.40
▸ LRRK2 Q5S007 6/20 0.39
▸ KDM1A O60341 1/20 0.35
▸ PDE4A P27815 1/20 0.34
▸ PDE4B Q07343 1/20 0.34
▸ PDE4C Q08493 1/20 0.34
▸ PDE4D Q08499 1/20 0.34
▸ BTK Q06187 3/20 0.33
▸ MEN1 O00255 3/20 0.33
▸ USP2 O75604 3/20 0.33
▸ CYP1A2 P05177 3/20 0.33
▸ CYP3A4 P08684 3/20 0.33
▸ CYP2D6 P10635 3/20 0.33
▸ CYP2C19 P33261 3/20 0.33
▸ KMT2A Q03164 3/20 0.33
▸ CLK4 Q9HAZ1 3/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ PRMT1 Q99873 1/20 0.32
▸ GRIN1 Q05586 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17469502 0.91 LRRK2 (0.40) PRMT5WDR77LRRK2KDM1AKCNH2
SCHEMBL16129425 0.87 HDAC6 (0.42) LRRK2PRMT1
SCHEMBL16120045 0.87 TTK (0.39) PRMT1
SCHEMBL17469470 0.86 HSP90AA1 (0.37) ALDH1A1PRMT1
SCHEMBL17469445 0.86 FADS1 (0.40) PRMT5WDR77PRMT1
SCHEMBL16119992 0.85 FADS1 (0.41) PRMT5WDR77PRMT1KCNH2
SCHEMBL17469453 0.83 PRMT1 (0.42) LRRK2ALDH1A1PRMT1
SCHEMBL17469449 0.83 PRMT1 (0.37) PRMT5WDR77LRRK2KDM1AALDH1A1
SCHEMBL17469509 0.83 PRMT1 (0.43) PRMT5WDR77CYP1A2CYP2D6PRMT1
SCHEMBL16129388 0.82 MAOB (0.43) KDM1ACYP3A4PRMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180105497-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2018-04-19 — — US disclosed
US-9765035-B2 Arginine methyltransferase inhibitors and uses thereof Epizyme, Inc. (US) 2017-09-19 — — US disclosed
US-20160024017-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2016-01-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160024017-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF PRMT1, PRMT3, PRMT5 PRMT5 3/4885WDR77 92/4885LRRK2 972/4885
US-20180105497-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF PRMT1, PRMT3, PRMT5 PRMT5 3/4885WDR77 92/4885LRRK2 972/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback